Author response: Progressive multifocal leukoencephalopathy after fingolimod treatment
Neurology
.
2019 Jan 15;92(3):151.
doi: 10.1212/WNL.0000000000006774.
Authors
Joseph R Berger
1
,
Bruce A Cree
2
,
Benjamin Greenberg
3
,
Bernhard Hemmer
4
,
Brian J Ward
5
,
Victor M Dong
6
,
Martin Merschhemke
7
Affiliations
1
(Philadelphia).
2
(San Francisco).
3
(Dallas).
4
(Munich).
5
(Montreal).
6
(East Hanover).
7
(Basel, Switzerland).
PMID:
30643034
DOI:
10.1212/WNL.0000000000006774
No abstract available
Publication types
Comment
MeSH terms
Fingolimod Hydrochloride
Humans
Leukoencephalopathy, Progressive Multifocal*
Multiple Sclerosis, Relapsing-Remitting*
Natalizumab
Substances
Natalizumab
Fingolimod Hydrochloride